CXCL12 and Alzheimer disease: Notably, a study by Sun et al. [25] observed that in AD, CXCL12 acts as a chemokine to recruit inflammatory cells, facilitating their migration regions by binding to CXCR4, thereby activating these cells to release inflammatory cytokines and accelerating the progression of inflammation [26].